Fecha
04-10-2006 al 06-10-2006

Lugar
Boston (EE.UU.)

Organizado por

The Global Investigators Meeting IV will convece investigators involved in the major clinical trials that comprise the Atorvastarin and Torcetrapib/Atorvastatin Phase III CLinical Trial Program (Measuring, Undestanding, and Researching, Atherosclerosis). The objectives of the meeting are to discuss recent atorvastatin and torcetrapib/atorvastatin clinical trial data in the context of area, and how these data are likely to shape futur strategies for preventing and managing cardiovascular disease.